Skip to main content
Clinical Trials/JPRN-jRCT1042230119
JPRN-jRCT1042230119
Recruiting
Phase 2

Trial to evaluate the efficacy of vibration positive expiratory pressure therapy in the perioperative period for esophageal cancer - CCOG2302

Kanda Mitsuro0 sites50 target enrollmentDecember 21, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Kanda Mitsuro
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 21, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kanda Mitsuro

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled for minimally invasive esophagectomy for curatively resectable esophageal cancer
  • Patients with an ECOG performance status (PS) of 0, 1, or 2
  • Cases in which the patient's written consent has been obtained

Exclusion Criteria

  • Cases in which split surgery is performed
  • Tracheostomies and cases with permanent tracheal holes
  • Cases of emergency surgery
  • Cases with a history of thoracic radiotherapy
  • Cases with severe lung diseases (interstitial pneumonia, pulmonary fibrosis, severe emphysema, etc.)
  • Patients with a history of clinically problematic mental disorders or central nervous system disorders
  • Cases in which spirometry is not feasible.
  • Patients with a history of pneumothorax
  • Cases in which the principal investigator or physician in charge judges that the patient is not suitable to participate in this study

Outcomes

Primary Outcomes

Not specified

Similar Trials